These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27896760)

  • 1. Opportunities and Challenges of Multiplex Assays: A Machine Learning Perspective.
    Chen J; Schwarz E
    Methods Mol Biol; 2017; 1546():115-122. PubMed ID: 27896760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Utility of Multiplex Assays for Identification of Proteomic Signatures in Psychiatry.
    Chen J; Guest PC; Schwarz E
    Adv Exp Med Biol; 2017; 974():131-138. PubMed ID: 28353229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges of Multiplex Assays for COVID-19 Research: A Machine Learning Perspective.
    Guest PC; Popovic D; Steiner J
    Methods Mol Biol; 2022; 2511():37-50. PubMed ID: 35838950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Clinical Translation of Biomarker Signatures: Statistical Considerations.
    Schwarz E
    Methods Mol Biol; 2017; 1546():103-114. PubMed ID: 27896759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients.
    Steiner J; Guest PC; Rahmoune H; Martins-de-Souza D
    Methods Mol Biol; 2017; 1546():19-35. PubMed ID: 27896755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel droplet platforms for the detection of disease biomarkers.
    Zec H; Shin DJ; Wang TH
    Expert Rev Mol Diagn; 2014 Sep; 14(7):787-801. PubMed ID: 25109704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein array-based companion diagnostics in precision medicine.
    Poulsen TBG; Karamehmedovic A; Aboo C; Jørgensen MM; Yu X; Fang X; Blackburn JM; Nielsen CH; Kragstrup TW; Stensballe A
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1183-1198. PubMed ID: 33315478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Multiplex Biomarker Approaches to Accelerate Drug Discovery and Development.
    Rahmoune H; Guest PC
    Methods Mol Biol; 2017; 1546():3-17. PubMed ID: 27896754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do we improve treatments for patients with amyloidosis using proteomics?
    Lavatelli F; Merlini G
    Expert Rev Proteomics; 2017 Jul; 14(7):561-563. PubMed ID: 28524784
    [No Abstract]   [Full Text] [Related]  

  • 11. From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay.
    Kraemer S; Vaught JD; Bock C; Gold L; Katilius E; Keeney TR; Kim N; Saccomano NA; Wilcox SK; Zichi D; Sanders GM
    PLoS One; 2011; 6(10):e26332. PubMed ID: 22022604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promise of biomarkers in cancer screening and detection.
    Negm RS; Verma M; Srivastava S
    Trends Mol Med; 2002 Jun; 8(6):288-93. PubMed ID: 12067615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease.
    Aydindogan E; Penque D; Zoidakis J
    Expert Rev Mol Diagn; 2019 Jan; 19(1):37-45. PubMed ID: 30560707
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of four protein biomarkers: An automated microfluidic cartridge-based method and its comparison to colorimetric ELISA.
    Dysinger M; Marusov G; Fraser S
    J Immunol Methods; 2017 Dec; 451():1-10. PubMed ID: 28917434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry analysis for amyloidosis typing - is the future bright for its clinical implementation?
    Hill MM; Mollee PN
    Expert Rev Proteomics; 2017 Jul; 14(7):565-566. PubMed ID: 28438056
    [No Abstract]   [Full Text] [Related]  

  • 17. Applying proteomics to detect early signs of chronic kidney disease: where has the magic gone?
    Klein JB
    Expert Rev Proteomics; 2017 May; 14(5):387-390. PubMed ID: 28363249
    [No Abstract]   [Full Text] [Related]  

  • 18. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities.
    Tetreault M; Bareke E; Nadaf J; Alirezaie N; Majewski J
    Expert Rev Mol Diagn; 2015 Jun; 15(6):749-60. PubMed ID: 25959410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and opportunities for oncology biomarker discovery.
    Deyati A; Younesi E; Hofmann-Apitius M; Novac N
    Drug Discov Today; 2013 Jul; 18(13-14):614-24. PubMed ID: 23280501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex Analyses Using Real-Time Quantitative PCR.
    Hawkins SFC; Guest PC
    Methods Mol Biol; 2017; 1546():125-133. PubMed ID: 27896761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.